Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
1.300
-0.030 (-2.26%)
At close: Oct 3, 2024, 4:00 PM
1.250
-0.050 (-3.85%)
After-hours: Oct 3, 2024, 6:09 PM EDT
Nektar Therapeutics Market Cap
Nektar Therapeutics has a market cap or net worth of $239.30 million as of October 3, 2024. Its market cap has increased by 85.65% in one year.
Market Cap
239.30M
Enterprise Value
173.79M
1-Year Change
85.65%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since December 1, 1998, Nektar Therapeutics's market cap has decreased from $478.60M to $239.30M, a decrease of -50.00%. That is a compound annual growth rate of -2.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2024 | 244.80M | 127.09% |
| Dec 29, 2023 | 107.80M | -74.62% |
| Dec 30, 2022 | 424.80M | -82.96% |
| Dec 31, 2021 | 2.49B | -18.24% |
| Dec 31, 2020 | 3.05B | -19.69% |
| Dec 31, 2019 | 3.80B | -33.26% |
| Dec 31, 2018 | 5.69B | -39.50% |
| Dec 29, 2017 | 9.40B | 401.47% |
| Dec 30, 2016 | 1.88B | -16.61% |
| Dec 31, 2015 | 2.25B | 12.95% |
| Dec 31, 2014 | 1.99B | 51.06% |
| Dec 31, 2013 | 1.32B | 54.43% |
| Dec 31, 2012 | 853.40M | 33.30% |
| Dec 30, 2011 | 640.20M | -47.19% |
| Dec 31, 2010 | 1.21B | 39.56% |
| Dec 31, 2009 | 868.60M | 68.99% |
| Dec 31, 2008 | 514.00M | -16.91% |
| Dec 31, 2007 | 618.60M | -54.96% |
| Dec 29, 2006 | 1.37B | -4.78% |
| Dec 30, 2005 | 1.44B | -15.13% |
| Dec 31, 2004 | 1.70B | 122.51% |
| Dec 31, 2003 | 763.80M | 70.57% |
| Dec 31, 2002 | 447.80M | -56.04% |
| Dec 31, 2001 | 1.02B | -55.42% |
| Dec 29, 2000 | 2.28B | 215.10% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ModivCare | 251.20M |
| Mersana Therapeutics | 250.26M |
| Sera Prognostics | 249.93M |
| Amarin Corporation | 248.35M |
| 2seventy bio | 247.71M |
| Delcath Systems | 242.21M |
| Corbus Pharmaceuticals Holdings | 242.20M |
| Fulcrum Therapeutics | 241.49M |